Egle Therapeutics
Yann Courbebaisse has extensive experience in non-clinical development, with a focus on toxicity, ADME/DMPK, and bio-analysis strategies to support program progression. With leadership roles in various pharmaceutical companies, Yann has a strong background in GLP bioanalysis, LC-MS analysis, DMPK studies, and biodistribution studies. Yann's career spans over two decades in the pharmaceutical industry, showcasing a deep understanding of preclinical research and development.
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.